Improvements in Quality of Life and Itch Symptoms with Dupilumab in Patients with Atopic Dermatitis: A Targeted Literature Review and Meta-Analysis of Real-World Studies

Main Article Content

Marjolein de Bruin-Weller
Jonathan Silverberg
Debra Sierka
Bruno Martins
Min Yang
Molly Frean
Patricia Guyot
Kerry Noonan
Zhixiao Wang
Gaëlle Bégo-Le-Bagousse


Atopic Dermatitis, Dermatology Life Quality Index, Dupilumab, Itch Symptoms, Meta-Analysis


1. Dupixent, INN – Dupilumab – European Medicines Agency. SmPC. 2022. Accessed August 5, 2023.

2. Halling, A.S., et al. J Am Acad Dermatol. 2021; 84(1): 139–147.

3. Fujiwara, C, et al. J Cutan Immun Allergy. 2023; 6(3): 88–93.

4. Hongbo, Y, et al. J Invest Dermatol. 2005;125: 659–64.

5. Reich, A, et al. Acta Derm Venereol. 2017; 97(6): 759–760.

Most read articles by the same author(s)

1 2 3 > >>